JULIA MARTYN: Open Payments
NPI 1255799680 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 23 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $57 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 12 | $323 |
| Neurocrine BioSciences, Inc. | 5 | $180 |
| Otsuka America Pharmaceutical, Inc. | 2 | $148 |
| Janssen Pharmaceuticals, Inc | 1 | $135 |
| Alkermes, Inc. | 1 | $121 |
| Collegium Pharmaceutical, Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: REXULTI, INGREZZA, INVEGA SUSTENNA, ARISTADA, Jornay PM, TRINTELLIX.
Industry payments across MA — which companies pay providers there.
